Category Archives: Stroke

StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Top Atrial Fibrillation (Afib) Articles of 2011

In follow up to our announcement yesterday of the Top Ten Atrial Fibrillation Videos of 2011, StopAfib.org now unveils the Top Ten Atrial Fibrillation Articles of 2011. Major topics of interest to the atrial fibrillation patient community this year were afib stroke prevention and the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Top Atrial Fibrillation (Afib) Videos of 2011

StopAfib.org has announced the Top Ten Atrial Fibrillation Videos of 2011. Afib stroke prevention again topped the list, with stories about warfarin (Coumadin), alternatives such as dabigatran (Pradaxa) and rivaroxaban (Xarelto), and the CHADS2 and CHA2DS2-VASc scoring tools for determining whether anticoagulants are needed. Other popular topics included sleep apnea, catheter ablation, and maze procedures (surgical …

Read More
Xarelto

FDA Approves Alternative to Warfarin — Rivaroxaban (Xarelto) Approved for Atrial Fibrillation Stroke Prevention

The US Food and Drug Administration has approved Xarelto (rivaroxaban) to reduce stroke risk in those with non-valvular atrial fibrillation (afib unrelated to heart valve problems). Xarelto is now the second oral alternative to warfarin (Coumadin) and offers an option for those unable to take warfarin or dabigatran. Xarelto is the first once-a-day alternative to …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

CHA2DS2-VASc or CHADS2 For Atrial Fibrillation Stroke Prevention? Should Aspirin Be Used? Video with Prof. Greg Lip

In this important video interview at Venice Arrhythmias, Professor Gregory Lip discusses the importance of the CHA2DS2-VASc scoring tool for predicting atrial fibrillation stroke risk and why aspirin is not appropriate for preventing strokes. Watch the video at: Professor Gregory Lip Discusses CHA2DS2-VASc Tool for Predicting Stroke Risk in Atrial Fibrillation — Video

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Atrial Fibrillation Awareness Month 2011 Happenings

Raising afib awareness is intensely personal for StopAfib.org founder, Mellanie True Hills, and led her to create the first Atrial Fibrillation Awareness Month in 2007. Working with other organizations, Hills helped urge the U.S. Senate to officially designate National Atrial Fibrillation Awareness Month in September 2009. This roundup recaps what happened during Afib Month 2011, …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Top Ten Surprising Things You Don’t Know about Afib

September is Atrial Fibrillation Awareness Month. Lots of folks don’t know too much about the condition, which is an irregular heart beat that can lead to serious complications such as dementia, heart failure, stroke or even death. To help spread the word, StopAfib.org presents these 10 afib facts and figures that will probably surprise even …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Atrial Fibrillation (Afib) Month Raises Awareness about this Common, Yet Unknown Condition

By Mellanie True Hills September is Atrial Fibrillation Awareness Month. A lot of folks may ask: Why do we need a month devoted to afib? Or, even, what is atrial fibrillation, anyway? Afib is an irregular heart beat that can lead to serious complications, such as dementia, heart failure, stroke, or even death. Too many …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Breaking News: FDA Panel Recommends Approval of Rivaroxaban (Xarelto) for Atrial Fibrillation Stroke Prevention

The US Food & Drug Administration (FDA) Advisory Committee just voted 9-2, with 1 abstaining, to recommend that the FDA approve rivaroxaban (Xarelto) for prevention of atrial fibrillation strokes. See our full story, now up at: FDA Panel Votes for Rivaroxaban: Atrial Fibrillation Patients May Soon Have Two Alternatives to Warfarin for Stroke Prevention

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

New report, How Can We Avoid a Stroke Crisis in Latin America?, Is Aimed at Avoiding Atrial Fibrillation Strokes

StopAfib.org is among a group of experts calling today for urgent action to prevent an atrial fibrillation stroke crisis in Latin America. Action for Stroke Prevention, a group of health experts from across the globe, is launching a new report, How Can We Avoid a Stroke Crisis in Latin America?, at the International Society for …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Rivaroxaban (Xarelto) Effective for Atrial Fibrillation Patients with High Stroke Risk

Just ahead of the FDA Advisory Committee hearing on rivaroxaban for stroke prevention in atrial fibrillation, we report in more depth on the ROCKET-AF trial results published recently in the New England Journal of Medicine. Rivaroxaban was shown to be as effective as warfarin (Coumadin) for stroke prevention in a high-risk afib population. To learn …

Read More